Browse > Article
http://dx.doi.org/10.4070/kcj.2014.44.4.255

miR-18a-5p MicroRNA Increases Vascular Smooth Muscle Cell Differentiation by Downregulating Syndecan4  

Kee, Hae Jin (Heart Research Center of Chonnam National University Hospital)
Kim, Gwi Ran (Heart Research Center of Chonnam National University Hospital)
Cho, Soo-Na (Heart Research Center of Chonnam National University Hospital)
Kwon, Jin-Sook (Division of Cardiovascular and Rare Diseases, Center for Biomedical Sciences, Korea National Institute of Health)
Ahn, Youngkeun (Heart Research Center of Chonnam National University Hospital)
Kook, Hyun (Department of Pharmacology and Medical Research Center for Gene Regulation, Chonnam National University Medical School)
Jeong, Myung Ho (Heart Research Center of Chonnam National University Hospital)
Publication Information
Korean Circulation Journal / v.44, no.4, 2014 , pp. 255-263 More about this Journal
Abstract
Background and Objectives: Differentiation and de-differentiation of vascular smooth muscle cells (VSMCs) are important events in atherosclerosis and restenosis after angioplasty. MicroRNAs are considered a key regulator in cellular processes such as differentiation, proliferation, and apoptosis. Here, we report the role of new miR-18a-5p microRNA and its downstream target genes in VSMCs and in a carotid balloon injury model. Materials and Methods: Expression of miR-18a-5p and its candidate genes was examined in VSMCs and in a carotid artery injury model by quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and microRNA microarray analysis. VSMC differentiation marker genes including smooth muscle (SM) ${\alpha}-actin$ and $SM22{\alpha}$ were determined by Western blot, qRT-PCR, and a $SM22{\alpha}$ promoter study. Gene overexpression or knockdown was performed in VSMCs. Results: miR-18a-5p was upregulated in the rat carotid artery at the early time after balloon injury. Transfection of the miR-18a-5p mimic promoted the VSMC differentiation markers SM ${\alpha}-actin$ and $SM22{\alpha}$. In addition, miR-18a-5p expression was induced in differentiated VSMCs, whereas it decreased in de-differentiated VSMCs. We identified syndecan4 as a downstream target of miR-18-5p in VSMCs. Overexpression of syndecan4 decreased Smad2 expression, whereas knockdown of syndecan4 increased Smad2 expression in VSMCs. Finally, we showed that Smad2 induced the expression of VSMC differentiation marker genes in VSMCs. Conclusion: These results indicate that miR-18a-5p is involved in VSMC differentiation by targeting syndecan4.
Keywords
miR-8a; Cell differentiation; Vascular smooth muscle; Syndecan4; Smad2 protein;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ohgawara T, Kubota S, Kawaki H, et al. Regulation of chondrocytic phenotype by micro RNA 18a: involvement of Ccn2/Ctgf as a major target gene. FEBS Lett 2009;583:1006-10.   DOI
2 Choe N, Kwon JS, Kim JR, et al. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis 2013;229:348-55.   DOI
3 Friedman LM, Dror AA, Mor E, et al. MicroRNAs are essential for development and function of inner ear hair cells in vertebrates. Proc Natl Acad Sci U S A 2009;106:7915-20.   DOI
4 Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005;65:9628-32.   DOI   ScienceOn
5 Kee HJ, Kwon JS, Shin S, Ahn Y, Jeong MH, Kook H. Trichostatin A prevents neointimal hyperplasia via activation of Kruppel like factor 4. Vascul Pharmacol 2011;55:127-34.   DOI
6 Kwon JS, Joung H, Kim YS, et al. Sulforaphane inhibits restenosis by suppressing inflammation and the proliferation of vascular smooth muscle cells. Atherosclerosis 2012;225:41-9.   DOI
7 Ikesue M, Matsui Y, Ohta D, et al. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization. Arterioscler Thromb Vasc Biol 2011;31:1066-74.   DOI
8 Matsui Y, Ikesue M, Danzaki K, et al. Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circ Res 2011;108:1328-39.   DOI
9 Herum KM, Lunde IG, Skrbic B, et al. Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress. J Mol Cell Cardiol 2013;54:73-81.   DOI
10 Ambros V. The functions of animal microRNAs. Nature 2004;431:350-5.   DOI   ScienceOn
11 Xie WB, Li Z, Shi N, et al. Smad2 and myocardin-related transcription factor B cooperatively regulate vascular smooth muscle differentiation from neural crest cells. Circ Res 2013;113:e76-86.   DOI
12 Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28:812-9.   DOI
13 Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801.   DOI   ScienceOn
14 He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-31.   DOI   ScienceOn
15 Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460:705-10.
16 Cheng Y, Liu X, Yang J, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009;105:158-66.   DOI
17 Li P, Zhu N, Yi B, et al. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ Res 2013;113:1117-27.   DOI
18 Leeper NJ, Raiesdana A, Kojima Y, et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011;226:1035-43.   DOI
19 Torella D, Iaconetti C, Catalucci D, et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 2011;109:880-93.   DOI
20 Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009;284:3728-38.   DOI   ScienceOn